These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25825402)

  • 21. Comparison of a dietary portfolio diet of cholesterol-lowering foods and a statin on LDL particle size phenotype in hypercholesterolaemic participants.
    Gigleux I; Jenkins DJ; Kendall CW; Marchie A; Faulkner DA; Wong JM; de Souza R; Emam A; Parker TL; Trautwein EA; Lapsley KG; Connelly PW; Lamarche B
    Br J Nutr; 2007 Dec; 98(6):1229-36. PubMed ID: 17663803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ezetimibe in clinical practice: from laboratory investigations to the IMPROVE-IT trial results].
    Borghi C; Filardi PP
    G Ital Cardiol (Rome); 2015; 16(7-8 Suppl 1):3S-14S. PubMed ID: 26442834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Is statin treatment for children safe and effective?].
    Marchetti F; Cannioto Z
    Recenti Prog Med; 2008 Dec; 99(12):599-601. PubMed ID: 19388217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomised trial of three counselling strategies for lifestyle changes in patients with hypercholesterolemia treated with ezetimibe on top of statin therapy (TWICE).
    Steg PG; Verdier JC; Carré F; Darne B; Ducardonnet A; Jullien G; Farnier M; Giral P; Haïat R;
    Arch Cardiovasc Dis; 2008; 101(11-12):723-35. PubMed ID: 19059567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JAMA patient page. Statins.
    Sugerman DT; Livingston EH; Lynm C
    JAMA; 2013 Apr; 309(13):1419. PubMed ID: 23549589
    [No Abstract]   [Full Text] [Related]  

  • 26. The Risk of Hepatotoxicity, New Onset Diabetes and Rhabdomyolysis in the Era of High-Intensity Statin Therapy: Does Statin Type Matter?
    Benes LB; Bassi NS; Davidson MH
    Prog Cardiovasc Dis; 2016; 59(2):145-152. PubMed ID: 27503844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When a statin fails.
    Med Lett Drugs Ther; 2009 Jul; 51(1317):58-60. PubMed ID: 19636290
    [No Abstract]   [Full Text] [Related]  

  • 28. A current approach to statin intolerance.
    Tompkins R; Schwartzbard A; Gianos E; Fisher E; Weintraub H
    Clin Pharmacol Ther; 2014 Jul; 96(1):74-80. PubMed ID: 24727470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study.
    Pedro-Botet J; Millán Núñez-Cortés J; Chillarón JJ; Flores-Le Roux JA; Rius J
    Expert Opin Drug Saf; 2016 Dec; 15(12):1583-1587. PubMed ID: 27645494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New statin guidelines: do they apply to you?
    Harv Health Lett; 2014 Feb; 39(4):8. PubMed ID: 24669404
    [No Abstract]   [Full Text] [Related]  

  • 31. Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle.
    Glueck CJ; Abuchaibe C; Wang P
    Med Hypotheses; 2011 Oct; 77(4):658-61. PubMed ID: 21802861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IMPROVE-IT clinical implications. Should the "high-intensity cholesterol-lowering therapy" strategy replace the "high-intensity statin therapy"?
    Masana L; Pedro-Botet J; Civeira F
    Atherosclerosis; 2015 May; 240(1):161-2. PubMed ID: 25795557
    [No Abstract]   [Full Text] [Related]  

  • 33. Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.
    Barter PJ; Rye KA
    Circulation; 2006 Sep; 114(12):1315-20; discussion 1320. PubMed ID: 16982953
    [No Abstract]   [Full Text] [Related]  

  • 34. [ANMCO Position paper: Diagnostic and therapeutic pathways in patients with hypercholesterolemia and statin intolerance].
    Gulizia MM; Colivicchi F; Arca M; Abrignani MG; Perna GP; Mureddu GF; Nardi F; Riccio C;
    G Ital Cardiol (Rome); 2016 Jun; 17(6):447-55. PubMed ID: 27311087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
    Fabbri G; Maggioni AP
    Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safety of statins in children.
    Lamaida N; Capuano E; Pinto L; Capuano E; Capuano R; Capuano V
    Acta Paediatr; 2013 Sep; 102(9):857-62. PubMed ID: 23631461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Are cholesterol target values still current?].
    Fueßl HS; Stiefelhagen P
    MMW Fortschr Med; 2015 Sep; 157(15):39. PubMed ID: 26349720
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes to the statin label: what they really mean.
    Harv Health Lett; 2012 May; 37(7):5. PubMed ID: 22737739
    [No Abstract]   [Full Text] [Related]  

  • 40. [Statin-associated muscle symptoms].
    Klose G
    MMW Fortschr Med; 2018 Jan; 160(1):40-43. PubMed ID: 29335944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.